Ethics
All aspects of doing research with integrity and honesty are being discussed in this section
The problem with science comics: uncritical images and ideology of research
Everything We Know About Astroscale’s Satellite for Cleaning Space Junk
The science and ethics of turning octopuses into ‘lab rats’
The Critical Ethos of the Open Society: A Reply to Esfeld [1]
Ethics in research issues
Let’s improve research culture together: MetisTalk wants to hear from you
Why we need to reimagine how we do research
Integrity is not a component of ethics, integrity is much more
Academic and research integrity cannot be a side project or an afterthought. Integrity and ethics must be central to everything we do and every decision we make. We must work to ensure that we are putting integrity at the forefront of our mission and operations. To achieve objectives mentioned it requests to respect the framework of integrity policies, processes and procedures at all institutional levels. Integrity policies, processes and procedures are an inseparable and significant part of the whole set of functions/activities within an institution that work together for the aim of the institution. Read more [...]
For centuries is plagiarism our companion
On the EU level there are the anti-plagiarism policies not defined in the higher education sector, although plagiarism-related projects are being supported. Read more [...]
Conflicting values of biomedical innovation?
The term ‘value’ is at the centre of an increasingly explicit debate in the fields of health and healthcare policy. ‘Value’ is understood in many different ways and diverging interests are being mobilised. How are values in biomedical innovation being expressed, represented, materialised and aligned or contested in different areas of biomedicine? How do values embedded in regulation, public health, economic policies, healthcare provision, technology assessment, producers' strategies, and patient organisation movements shape biomedical innovations? At an ESOF discussion in Toulouse multidisciplinary perspectives on value between panel members and public participants will be explored and possible pathways to common solutions identified that promote socially acceptable biomedical innovation in the European context. Read more [...]
EU trachea transplant clinical trial TETRA “uncertain to take place”
The scandal of regenerative medicine surgeon Paolo Macchiarini and his deadly plastic tracheas made world news. Yet this human abuse, which started at the Karolinska Institutet in Sweden, was just a part of a much bigger horror story. The suffering and deaths of other trachea transplant patients of Macchiarini and his collaborators, those who received a decellurised cadaveric trachea, is much less known. I focused my reporting on it, bringing back to memory all those dead patients which the hospitals in London, Florence and Barcelona pretend never existed. Presently, 62 patients were scheduled to be treated with decellurised cadaveric trachea in two phase 1 clinical trials in UK and one EU-funded phase 2 clinical trial, all led by former Macchiarini partner, UCL laryngologist Martin Birchall. But now, all 3 clinical trials are not going anywhere. Read more [...]